Barbro Ek-Rylander Selected Research

purple acid phosphatase

11/2015	The small chemical enzyme inhibitor 5-phenylnicotinic acid/CD13 inhibits cell migration and invasion of tartrate-resistant acid phosphatase/ACP5-overexpressing MDA-MB-231 breast cancer cells.
1/2011	Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbro Ek-Rylander Research Topics

Disease

5	Breast Neoplasms (Breast Cancer) 03/2020 - 05/2010
4	Neoplasms (Cancer) 03/2020 - 01/2011
3	Neoplasm Metastasis (Metastasis) 09/2017 - 01/2011
2	Bone Resorption 04/2010 - 02/2010
1	Bone Diseases (Bone Disease) 01/2011
1	Inflammation (Inflammations) 01/2011
1	Melanoma (Melanoma, Malignant) 06/2010
1	Choriocarcinoma 04/2005

Drug/Important Bio-Agent (IBA)

6	Tartrate-Resistant Acid PhosphataseIBA 03/2020 - 04/2005
3	Proteins (Proteins, Gene)FDA Link 03/2020 - 01/2011
3	Protein Isoforms (Isoforms)IBA 03/2020 - 05/2010
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2020 - 02/2010
2	purple acid phosphataseIBA 11/2015 - 01/2011
1	Peptide Hydrolases (Proteases)FDA Link 03/2020
1	Cathepsin KIBA 03/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2017
1	tissue-factor-pathway inhibitor 2 (PP5)IBA 11/2015
1	AcidsIBA 11/2015
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 11/2015
1	EnzymesIBA 11/2015
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	FilaminsIBA 06/2010
1	Prothrombin (Factor II)IBA 04/2010
1	Thrombin FDA Link 04/2010
1	OsteopontinIBA 04/2005
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 04/2005

Therapy/Procedure

1	Therapeutics 11/2015